Approval · Notice of Compliance 19272 · 2017
TECHNIVIE: Notice of Compliance 19272
Issued May 5, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19272
- Date
- May 5, 2017
- Company
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To revise the indication to include patients with chronic hepatitis C virus genotype 4 who have compensated cirrhosis
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TECHNIVIE | Not yet assigned | — |
Medicinal ingredients
- RITONAVIR 50 MG per TAB
- PARITAPREVIR 75 MG per TAB
- OMBITASVIR 12.5 MG per TAB